Abstract
We have examined the roles of Fc receptors and complement receptors in mediating the interaction of sensitized sheep erythrocytes (E) with activated and with nonactivated mouse peritoneal macrophages. Both activated and nonactivated macrophages ingest IgG-coated erythrocytes [E(IgG)]; activated cells intest 1.5-2 times as man E(IgG) as do nonactivated macrophages. Thus, there is a quantitative difference in Fc receptor-mediated ingestion between activated and nonactivated macrophages. There is, however, a qualitative difference in function of complement receptors of activated and nonactivated macrophages. Nonactivated macrophages avidly bind complement-coated E [E(IgM)Ia1, but do not ingest them to a significant degree. Activated macrophages, on the other hand, bind and ingest E(IgM)C. The possibility of Fc receptor participation in mediating ingestion of E(IgM)C by activated macrophages was eliminated by blocking Fc receptors with an antimacrophage IgG fraction. Activated macrophages treated with antimacrophage IgG did not ingest E(igG) but did ingest both E(IgM)C AND E(IgM)C. Nonactivated macrophages treated with antimacrophage IgG did not interact at all with E(IgG). These cells bound, but did not ingest, E(IgM)C and E(IgM)C. Complement receptor-mediated ingestion is a marker for macrophage activation and may be physiologically important in the elimination of complement-coated particles.
MeSH Terms
Animals
Binding Sites
Binding Sites, Antibody
Complement System Proteins/metabolism
Immunoglobulin Fab Fragments/metabolism
Immunoglobulin Fc Fragments/metabolism
Immunoglobulin G/metabolism
Immunoglobulin M/metabolism
Macrophages/immunology
Mice
Phagocytosis
Rabbits/immunology
Sheep/immunology
Stimulation, Chemical
Thioglycolates/pharmacology
Trypsin/pharmacology
Chemicals
Immunoglobulin Fab Fragments
Immunoglobulin Fc Fragments
Immunoglobulin G
Immunoglobulin M
Thioglycolates
Complement System Proteins
Trypsin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Bianco C
Griffin F M
Silverstein S C
References (23)
23 references, click to expand
-
THE DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES. MORPHOLOGY, CYTOCHEMISTRY, AND BIOCHEMISTRY.
J Exp Med. 1965 Jan 1;121:153-70
PMID: 14253481
-
THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE.
J Exp Med. 1964 Jul 1;120:105-20
PMID: 14194388
-
Improvements in epoxy resin embedding methods.
J Biophys Biochem Cytol. 1961 Feb;9:409-14
PMID: 13764136
-
Plaque formation and isolation of pure lines with poliomyelitis viruses.
J Exp Med. 1954 Feb;99(2):167-82
PMID: 13130792
-
Protein measurement with the Folin phenol reagent.
J Biol Chem. 1951 Nov;193(1):265-75
PMID: 14907713
-
Characterization of a lymphocyte factor which alters macrophage functions.
J Exp Med. 1973 Feb 1;137(2):275-90
PMID: 4119587
-
Cellular immunity in vitro. I. Immunologically mediated enhancement of macrophage bactericidal capacity.
J Exp Med. 1971 Jun 1;133(6):1377-89
PMID: 4102688
-
Enhancement of macrophage bactericidal capacity by antigenically stimulated immune lymphocytes.
Cell Immunol. 1972 Jun;4(2):163-74
PMID: 4112849
-
Receptors for complement of leukocytes.
J Exp Med. 1968 Nov 1;128(5):991-1009
PMID: 4176227
-
Properties of antibodies cytophilic for macrophages.
J Exp Med. 1966 Jan 1;123(1):119-44
PMID: 4159249
-
Segmental response of the macrophage plasma membrane to a phagocytic stimulus.
J Exp Med. 1974 Feb 1;139(2):323-36
PMID: 4149357
-
The enhancement of macrophage bacteriostasis by products of activated lymphocytes.
J Exp Med. 1973 Oct 1;138(4):952-64
PMID: 4200649
-
The effect of Bacillus Calmette-Guerin-induced macrophage activation on the in vivo clearance of sensitized erythrocytes.
J Clin Invest. 1974 Jun;53(6):1742-9
PMID: 4598114
-
Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b.
J Exp Med. 1973 Oct 1;138(4):798-811
PMID: 4542735
-
Human lymphocytes bear membrane receptors for C3b and C3d.
J Clin Invest. 1973 Dec;52(12):3239-42
PMID: 4543024
-
The selective inhibition of macrophage phagocytic receptors by anti-membrane antibodies.
J Exp Med. 1972 Mar 1;135(3):458-75
PMID: 4550767
-
Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites.
J Clin Invest. 1972 Mar;51(3):575-82
PMID: 4536807
-
Secretion of plasminogen activator by stimulated macrophages.
J Exp Med. 1974 Apr 1;139(4):834-50
PMID: 4816302
-
Phagocytosis of immune complexes by macrophages. Different roles of the macrophage receptor sites for complement (C3) and for immunoglobulin (IgG).
J Exp Med. 1972 Apr 1;135(4):780-92
PMID: 5018051
-
Ultrastructure of human leukocytes after simultaneous fixation with glutaraldehyde and osmium tetroxide and "postfixation" in uranyl acetate.
J Cell Biol. 1968 Sep;38(3):615-27
PMID: 4874495
-
Characterization of the macrophage receptro for complement and demonstration of its functional independence from the receptor for the Fc portion of immunoglobulin G.
J Exp Med. 1975 Jun 1;141(6):1269-77
PMID: 1092796
-
Alterations of macrophage functions by mediators from lymphocytes.
J Exp Med. 1971 Jun 1;133(6):1356-76
PMID: 5576335
-
Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.
Exp Cell Res. 1968 Jul;51(1):45-67
PMID: 5661952